Cargando…
Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154427/ https://www.ncbi.nlm.nih.gov/pubmed/12716441 http://dx.doi.org/10.1186/ar607 |
_version_ | 1782120748424364032 |
---|---|
author | Einhorn, Thomas A |
author_facet | Einhorn, Thomas A |
author_sort | Einhorn, Thomas A |
collection | PubMed |
description | Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX-1. Although these data raise concerns about the use of COX-2-specific inhibitors as anti-inflammatory or anti-analgesic drugs in patients undergoing bone repair, clinical reports have been inconclusive. Because animal data suggest that the effects of COX-2 inhibitors are both dose-dependent and reversible, in the absence of scientifically sound clinical evidence it is suggested that physicians consider short-term administration or other drugs in the management of these patients. |
format | Text |
id | pubmed-154427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1544272003-05-07 Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair Einhorn, Thomas A Arthritis Res Ther Commentary Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX-1. Although these data raise concerns about the use of COX-2-specific inhibitors as anti-inflammatory or anti-analgesic drugs in patients undergoing bone repair, clinical reports have been inconclusive. Because animal data suggest that the effects of COX-2 inhibitors are both dose-dependent and reversible, in the absence of scientifically sound clinical evidence it is suggested that physicians consider short-term administration or other drugs in the management of these patients. BioMed Central 2003 2002-10-21 /pmc/articles/PMC154427/ /pubmed/12716441 http://dx.doi.org/10.1186/ar607 Text en Copyright © 2003 BioMed Central Ltd |
spellingShingle | Commentary Einhorn, Thomas A Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title | Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title_full | Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title_fullStr | Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title_full_unstemmed | Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title_short | Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair |
title_sort | cox-2: where are we in 2003? - the role of cyclooxygenase-2 in bone repair |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154427/ https://www.ncbi.nlm.nih.gov/pubmed/12716441 http://dx.doi.org/10.1186/ar607 |
work_keys_str_mv | AT einhornthomasa cox2wherearewein2003theroleofcyclooxygenase2inbonerepair |